Dergiler / Eurasian Journal of Medicine and Oncology / 2020 / Cilt: 4 - Sayı: 2

Case Fatality Rate estimation of COVID-19 for European Countries: Turkey’s Current Scenario Amidst a Global Pandemic; Comparison of Outbreaks with European Countries

Sayfa
149–159
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This study was aimed at recording an update on the current epidemiological situation of COVID-19 for Turkey in comparison to European countries during a global pandemic.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: SARS-CoV-2 belonging to Coronaviridae family of RNA viruses caused an epidemic in China, which led to a global pandemic of COVID-19.
📊
Temel Bulgular & Veri:Case fatality rate is one of the key parameter for epidemiology of an outbreak of this kind.
💡
Sonuç & Katkı:This study was aimed at recording an update on the current epidemiological situation of COVID-19 for Turkey in comparison to European countries during a global pandemic.
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: SARS-CoV-2 belonging to Coronaviridae family of RNA viruses caused an epidemic in China, which led to a global pandemic of COVID-19. Various international and national authorities around the world have been attempting to halt the spread of the deadly virus by providing awareness about the disease including the daily figures of confirmed cases and mortalities related to the pandemic. At this early stage of this outbreak, healthcare officials and public, require the epidemiological patterns to understand the situation. Case fatality rate is one of the key parameter for epidemiology of an outbreak of this kind. Here, we aimed to compute the CFR for European countries and Turkey until 31st March 2020. Methods: We used linear regression analysis on cumulative number of cases and deaths for constructing a slope for estimating CFR values of COVID-19 in selected countries. We compared the computed CFR values of Turkey until 31st March (15 days since first COVID-19 death) with similar first fifteen days’ data since the report of first death from Italy, Spain, UK, France, Germany, Switzerland, Belgium, Austria, Netherlands and Portugal. Later, we computed CFR values for these countries from their cumulative confirmed cases and cumulative deaths until 31st March. Results: This data driven analysis showed that CFR for Turkey was 1.85 (95% CI: 1.513-2.181) with R2 value of 0.92 which was comparable to fifteen day analysis of France as 1.979 (95% CI: 1.798-2.159) and R2 value of 0.98. However, CFRs for selected countries increased in subsequent analysis when the threshold of fifteen days was released until March 31, 2020. However, the CFR estimates are time dependent and show linear trend in initial stages of the outbreak. Conclusions: Our findings suggest that the CFR of COVID-19 in Turkey at initial stages of the outbreak was similar to France. However, SARS-CoV-2 seemed to have spread quicker in Turkey since the report of first death, as compared to other countries based on the number of confirmed cases. This study was aimed at recording an update on the current epidemiological situation of COVID-19 for Turkey in comparison to European countries during a global pandemic.

🔖

Bu Makaleye Atıf Yap

ÖZTOPRAK, F., JAVED, A. (2020). Case Fatality Rate estimation of COVID-19 for European Countries: Turkey’s Current Scenario Amidst a Global Pandemic; Comparison of Outbreaks with European Countries. Eurasian Journal of Medicine and Oncology, Cilt: 4 - Sayı: 2, 149–159. https://ajindex.com/articles/124571

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Wassenaar TM, Zou Y. 2019_nCoV: Rapid classification of betacoronaviruses and identification of traditional Chinese medicine as potential origin of zoonotic coronaviruses. Letters in Applied Microbiology. 2020
  2. Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infection, Genetics and Evolution. 2020;79:104212
  3. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Mar 9
  4. Liu C, Yang Y, Gao Y, Shen C, Ju B, Liu C, Tang X, Wei J, Ma X, Liu W, Xu S. Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EM. bioRxiv. 2020 Jan 1
  5. Gorbalenya AE. Severe acute respiratory syndrome-related coronavirus–The species and its viruses, a statement of the Coronavirus Study Group. BioRxiv. 2020 Jan 1
  6. Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019‐new coronavirus epidemic: evidence for virus evolution. Journal of Medical Virology 2020;92:455–9
  7. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020;395:565–74
  8. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID- 19). Journal of General Internal Medicine 2020:1–5
  9. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A. Clinical, laboratory and imaging features of COVID-19: A systematic review and metaanalysis. Travel medicine and infectious disease 2020:101623. 10. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology 2016;14:523
  10. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses 2019;11:59
  11. World Health Organization. Coronavirus disease 2019 (COVID- 19): situation report, 59
  12. Lai A, Bergna A, Acciarri C, Galli M, Zehender G. Early phylogenetic estimate of the effective reproduction number of S